Skip to main content

Table 2 Tumor antigen and HLA-class I expression in resected tumors

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Patient

hHLA-typing

Tumor antigen expression

HLA-class Ia

1

A*2402

N. D.

N. D. b

2

A*2402

5/5 (M1, M3, HER2, gp100, WT-1)

++

3

A*2402

5/5

+

4

A*2402

N. D.

N. D.

5

A*2402

3/5 (M3, HER2, WT-1)

+

6

A*2402

5/5

+

7

A*0201

5/5

+

8

A*2402

N. D.

N. D.

9

A*2402

5/5

+

  1. aHLA-class I expression was checked on IHC, b N. D. ; not done.